Venous thromboembolism and cancer: pathophysiology and incidence

被引：17

作者：

Stricker, Hans ^{[1
]}

机构：

[1] Osped La Carita, CH-6600 Locarno, Switzerland

来源：

VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE | 2014年 / 43卷 / 04期

关键词：

Cancer; thrombosis; incidence; pathophysiology; prothrombotic state; BLEEDING COMPLICATIONS; PULMONARY-EMBOLISM; RISK; THROMBOSIS; MICROPARTICLES; COAGULATION; MALIGNANCY;

D O I：

10.1024/0301-1526/a000358

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

A relationship between tumor and thrombosis is well known. This review covers the aspect of incidence and pathophysiology of cancer-related thromboembolism. Cancer patients have an up to 7% risk of developing venous thrombosis, partly because they are subject to various circumstantial risk factors such as surgical interventions, immobilization or drugs during their illness. On the other hand, tumors frequently generate a prothrombotic state, which may remain without clinical manifestation or result in anticoagulant-resistent venous thromboembolism. Recently discovered thrombosis-generating mechanisms could help to classify patients in categories with high and low thrombotic risk, which will allow tailored prophylactic and therapeutic interventions.

引用

页码：239 / 243

页数：5

共 50 条

[41] Incidence of Venous Thromboembolism in Patients With and Without Extended Venous Thromboembolism Prophylaxis
Torres Garcia, Antonio Jose
Cano Valderrama, Oscar
OBESITY SURGERY, 2010, 20 (06) : 819 - 819
[42] Preeclampsia and Venous Thromboembolism: Pathophysiology and Potential Therapy
Raia-Barjat, Tiphaine
Edebiri, Osasere
Ni Ainle, Fionnuala
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[43] Pathophysiology of Venous Thromboembolism: Putative role of HDL
Kumar, Vinav
Garg, Iti
Srivastava, Swati
Ganju, Lilly
Varshney, Rajeev
FASEB JOURNAL, 2022, 36
[44] The Pathophysiology of Venous Thromboembolism: Implications With Compression Garments
Clayman, Mark A.
Clayman, Eric S.
Seagle, Brent M.
Sadove, Richard
ANNALS OF PLASTIC SURGERY, 2009, 62 (05) : 468 - 472
[45] Incidence of Venous Thromboembolism during Chemotherapy for Breast Cancer: Impact on Cancer Outcome
Kirwan, Cliona C.
Mcdowell, Garry
Mccollum, Charles N.
Byrne, Gerard J.
ANTICANCER RESEARCH, 2011, 31 (06) : 2383 - 2388
[46] Cancer begets venous thromboembolism, but is venous thromboembolism a risk factor for cancer?
White, R. H.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) : 543 - 545
[47] Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status
L. Ortega Morán
P. García Alfonso
I. Aguilar Caballero
B. Morón García
V. Tirado Anula
M. de Toro Carmena
J. Soto Alsar
N. Gutiérrez Alonso
M. Bringas Beranek
M. Martín Jiménez
A. J. Muñoz Martín
Clinical and Translational Oncology, 2020, 22 : 2026 - 2031
[48] High incidence of silent venous thromboembolism before treatment in ovarian cancer
Satoh, T.
Oki, A.
Uno, K.
Sakurai, M.
Ochi, H.
Okada, S.
Minami, R.
Matsumoto, K.
Tanaka, Y. O.
Tsunoda, H.
Homma, S.
Yoshikawa, H.
BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1053 - 1057
[49] Incidence and Effects on Mortality of Venous Thromboembolism in Elderly Women With Endometrial Cancer
Rauh-Hain, J. Alejandro
Hariton, Eduardo
Clemmer, Joel
Clark, Rachel M.
Hall, Tracilyn
Boruta, David M.
Schorge, John O.
del Carmen, Marcela G.
OBSTETRICS AND GYNECOLOGY, 2015, 125 (06): : 1362 - 1370
[50] Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer
Ortega Moran, L.
Pesantez, D.
Brozos Vazquez, E.
Fernandez Garay, D.
Lobo de Mena, M.
Ribera Fernandez, P.
Sanchez Canovas, M.
Salgado, M.
Garcia Perez, E.
Iriarte Moncho, E.
Moron Garcia, B.
Font, C.
Gallardo, E.
Perez Altozano, J.
Munoz Martin, A.
THROMBOSIS RESEARCH, 2022, 213 : S20 - S20

← 1 2 3 4 5 →